C ardiotropic viral infections are important causative factors in dilated cardiomyopathy (DCM), which appears to occur as a late sequela of acute viral myocarditis. [1] [2] [3] [4] In the past, mostly enteroviruses (EVs) have been identified [5] [6] [7] and are associated with unfavorable clinical and hemodynamic outcomes. 3, 8, 9 Recently, other viral genomes have been detected in endomyocardial biopsies (EMB) from adults who presented with the clinical phenotype of acute or chronic myocarditis and DCM. Among identified viral genomes that have been reported in EMBs of Ϸ67% of patients with this clinical setting, parvovirus B19 (PVB19) and human herpesvirus type 6 (HHV6) are the most frequently encountered pathogens. 3, 4, 10 The natural course and possible relevance of persistent viral infection for improvement, persistence, or progression of myocardial dysfunction are currently unknown. The present study was a biopsy-based analysis of the spontaneous course of cardiac infections with various viruses in follow-up biopsies of patients with regionally or globally impaired myocardial function.
Methods

Patients
Between July 2001 and September 2004, 841 patients were admitted to our institution for EMB to further elucidate a possible inflammatory and/or infectious cause of their disease because the clinical presentation had suggested myocarditis in the past or DCM. In this study, we enrolled 172 consecutive patients in whom polymerase chain reaction (PCR) analysis had detected viral genomes in the biopsy sample at the initial clinical presentation. Patients clinically presenting with acute myocarditis of recent onset with signs of myocardial injury (eg, mimicking acute myocardial infarction) were not included. The majority of enrolled patients (89%) complained of symptoms of moderate heart failure with fatigue, reduced physical capacity, or dyspnea on exertion. Most patients were in New York Heart Association classes II and III (II, 68%; III, 30%; and IV, 2%).
The demographic and clinical characteristics of patients are shown in Tables 1 and 2 .
Coronary artery disease and other possible causes of myocardial dysfunction had been excluded by angiography before biopsy in all patients. At the baseline biopsy, the patients presented with either regional (35%) or global (65%) wall motion abnormalities. To determine the course of the viral infection, all patients underwent follow-up biopsy. Ejection fraction (EF) was determined angiographically. Additionally, standard 2-dimensional and M-mode echocardiography was performed for all patients in our echocardiographic department 1 day before biopsy (median interval, 6.8 months; range, 5.4 to 11.9). For each echocardiogram, left ventricular (LV) end-diastolic (LVEDD) and end-systolic (LVESD) diameters were measured by M-mode echocardiography in the parasternal long-axis view according to the leading-edge method. Percentage fractional shortening was calculated in a standardized manner. Medication use, including angiotensin-converting enzyme inhibitors, ␤-blockers, diuretics, cardiac glycosides, and warfarin, was stable throughout the follow-up period without significant differences between patients who developed virus genome persistence and those who did not.
EMB and Right-Heart Catheterization
Eight EMBs were obtained from the right side of the ventricular septum of each patient with use of a flexible bioptome (Westmed) via the femoral vein approach. There were no biopsy-related adverse events. Two EMBs were used for histological evaluation according to the Dallas criteria 11 and immunohistochemistry, 6 whereas the remaining 4 EMBs were subjected to DNA and RNA extraction for amplification of the viral genomes. After the EMBs were obtained, the patients underwent right heart catheterization. Right atrial, right ventricular, pulmonary arterial, and pulmonary capillary wedge pressures (all in mm Hg) and cardiac index (L · min Ϫ1 · m Ϫ2 body surface area) were recorded. The protocol was approved by the Human Research Committee of the Charite, Campus Benjamin Franklin, Berlin, and all patients gave written, informed consent before treatment.
Etiologic Investigations
Detection of Viral Genomes by Nested PCR
Detection of viral genomes by nested PCR was carried out as published recently. 3, 4, 12 In brief, nested PCR/reverse transcription-PCR was performed on RNA extracted from EMBs for EVs (including coxsackieviruses and echoviruses) and in DNA for adenovirus (ADV), PV, and HHV6. As a control for successful extraction of DNA and RNA from heart muscle tissue, oligonucleotide sequences were chosen from the DNA sequence of the glyceraldehyde 3-phosphate dehydrogenase gene. Specificity of all amplification products was confirmed by automatic DNA sequencing. [12] [13] [14] 
Histological and Immunohistological Evaluation
Myocardial inflammation was defined by the detection of infiltrating lymphocytes (median cell count Ͼ7.0 cells/mm 2 ) in association with enhanced expression of cellular adhesion molecules (HLA-I/II or CD54) expressed on interstitial or endothelial cells. 15, 16 Samples containing low numbers of infiltrating lymphocytes (median cell count Ͻ7.0 cells/mm 2 ), especially those without enhanced cellular 
Results
Biopsy Findings
At baseline, 63 (36.6%) of the 172 patients' EBMs were positive for PVB19, 56 (32.6%) for EV, 18 (10.5%) for HHV6, and 14 (8.1%) for ADV. Dual infection with PVB19 and HHV6 was present in 21 (12.2%) biopsy specimens ( Table 3 ). The spontaneous course of viral infections in these 172 patients was followed up for a median of 6.8 months (range, 5.4 to 11.9). At the time of the follow-up biopsy, spontaneous clearance of viral genomes was found in 55 
05).
Enhanced HLA-I/DR and CD54 expression was significantly correlated with infiltrating inflammatory cells, but it was independent of the course of viral infection (data not shown).
Hemodynamic Course
Regardless of the virus involved, complete clearance of viral genomes (nϭ64) was associated with a significant improvement in LVEF, improving from 50.2Ϯ19.1% to 58.1Ϯ15.9% (PϽ0.001, Figure 1 ). An increase in systolic LV function was found to be independent of the infectious agent. In contrast to the favorable hemodynamic course of patients who eliminated the viral genomes, virus persistence was associated with a lack of hemodynamic improvement. Between baseline and follow-up, LVEF significantly decreased from 54.3Ϯ16.1% to 51.4Ϯ16.1% (PϽ0.01) in these patients (nϭ108), despite the relative short follow-up period of 6.8 months. Hemodynamic changes after spontaneous HHV6 clearance but PVB19 persistence were not significant (Pϭ0.49) in patients with PVB19/HHV6 dual infection, whereas persistence of both viruses was associated with a mild progression of LV dysfunction (Pϭ0.06). Hemodynamic improvement occurred in patients with both mild and severe LV dysfunction. The improvement was more pronounced in patients with an EF Ͻ45% (nϭ51) compared with patients with an EF Ͼ45% (Figure 2 ). In this subgroup, EF improved from 29.6Ϯ7.8% to 44.0Ϯ13.6% (PϽ0.001, nϭ24) in association with virus elimination, whereas EF did not change in patients who developed viral persistence (32.4Ϯ8.4% versus 33.9Ϯ15.8%, Pϭ0.57). In patients with an EF Ͼ45% (nϭ121), EF improved from 62.6Ϯ11.5% to 66.6Ϯ10.1% (PϽ0.01, nϭ40) or deteriorated from 61.6Ϯ10.4% to 57.2Ϯ11.2% (PϽ0.001, nϭ81). The aforementioned hemodynamic changes were independent of the patients' medication regimen, which did not differ significantly between the virus-positive and virus-negative cohorts and that had been kept constant during the follow-up period. In contrast to the viral course, changes in myocardial inflammatory cells were not additional predictors of the hemodynamic course.
Discussion Relation Between Clinical and Virological Course
A broad spectrum of viral genomes has been detected in EMBs from patients with clinically suspected myocarditis in the past and DCM. So far, EVs have been linked to the development of myocarditis and its progression to DCM. 1, 2 Recently, we and others have detected other frequent viral genomes (eg, ADV, PVB19, and HHV6) in the myocardium of patients presenting with acute heart failure caused by myocarditis, with a sudden onset of cardiac symptoms mimicking acute myocardial infarction and with chronic LV dysfunction diagnosed as "idiopathic" DCM. [3] [4] [5] [6] [7] 17 The natural course of these viral infections and the prevalence of viral persistence in these groups have not been investigated yet. To address this issue and to elucidate the relevance of virus persistence with respect to LV function, we conducted follow-up EMBs in 172 consecutive, virus-positive patients with persistent LV dysfunction.
During follow-up of patients with clinically suspected myocarditis in the past or with heart failure of unknown origin, one may observe either "spontaneous" improvement or progression of ventricular dysfunction despite constant Kühl et al Natural Course of Virus-Associated Heart Diseaseheart failure medication. Our results suggest that these "spontaneous" changes in cardiac function may actually reflect the dynamic course of an underlying cardiotropic viral infection. As shown here, virus clearance was associated with a spontaneous improvement in LVEF, regardless of the type of virus involved. It appears that patients with a lower EF (Ͻ45%) improve more than do those with milder EF dysfunction. This is reminiscent of a similar phenomenon in a prior study of interferon-␤-induced virus elimination. 12 LVEF did not improve or even deteriorated in patients with viral persistence. Taking into consideration the slow but continuous development of LV dysfunction in DCM, the even mild deterioration of LVEF observed during the short follow-up period of 6.8 months may progress to substantial myocardial dysfunction over years.
Molecular Pathomechanisms of Viral Heart Disease
Even small amounts of persistent viral genomes may cause further progression of the disease, by direct cytopathic effects of virus-encoded proteins via virus-associated signaling pathways resulting in the release of cytokines, 18 -25 by alterations of the extracellular cardiac matrix or the cytoskeleton, 26 -28 or by chronic myocardial inflammation. 15, 16, 29, 30 So far, the causes of the highly variable natural courses of virusassociated heart disease are unknown but may include changes in cardiac virus load, as well as the host's primary immune responses to the virus. If the viruses were cleared spontaneously and thus, no pathogenic agents were detected in the myocardium, diagnostic procedures should result in resolved myocarditis or "idiopathic" DCM. In patients with "resolved" myocarditis, ventricular function may recover completely if the initial myocardial damage was minor. In other patients, persistence or further progression of ventricular dysfunction may result from myocardial remodeling after the initial virus-induced injury of cardiac tissues.
Myocardial inflammation was detected in 40% of the virus-positive patients during baseline EMB. This inflammation was significantly reduced at follow-up but still primarily seen in virus-positive patients (23.9% versus 12.5%, PϽ0.05, respectively). Further follow-up of virus-negative patients with inflammation would be required to distinguish an inflammatory process resolving after virus clearance from virus-induced persistent inflammation, often referred to as and indistinguishable from (auto)immune myocarditis or chronic inflammatory cardiomyopathy.
Conclusions
A broad spectrum of viral genomes has been detected in patients with de novo wall motion abnormalities or persistent LV dysfunction, clinically often referred to as past myocarditis or DCM. The influence of this chronic viral infection on myocardial function is unknown, because biopsy-based follow-up data on patients infected with these viruses have never been obtained. By following up a large cohort of patients with different virus infections, we could show that spontaneously occurring virus clearance is associated with spontaneous hemodynamic improvement. In contrast, LV function deteriorates in patients with virus persistence, even within a short follow-up period of 6.8 months and despite constant heart failure medication. These data indicate that persisting cardiac viral infections may constitute a major cause of progressing LV dysfunction in patients with clinically suspected past myocarditis or DCM. The data furthermore indicate that only an EMB-derived virus analysis allows accurate diagnosis in patients with clinically suspected myocarditis or DCM, which is mandatory for effective antiviral immunomodulatory treatment of these patients.
